Founded in 2021, Pomelo Care delivers 24/7 virtual care to women and children via a multispecialty clinical team supported by an intelligent, data-driven platform that surfaces risk early and guides evidence-based interventions. The company partners with commercial and Medicaid health plans and employers, now covering more than 25 million lives and supporting nearly 7 % of all U.S. births. Outcomes published in peer-reviewed venues show a 37 % reduction in preterm births, a 46 % cut in emergency room visits, and a 6.8-day decrease in NICU length of stay, generating a 3-5× ROI for customers. Its technology embeds predictive analytics and clinical playbooks directly into clinician workflows while giving patients multimodal access to nurses, dietitians, therapists, doulas, and other providers. Beyond maternity, Pomelo has launched programs for pediatrics and midlife care; its perimenopause/menopause program has achieved an 88 % symptom reduction within 60 days and boosted patient-reported productivity by 73 %. With a proven model and national scale, the company aims to establish a new standard of longitudinal care for women and children while continuing rapid expansion with payers and employers.

Total raised

$171M

Funding rounds

3

Latest round

Series C

Latest activity

Jan 2026